 |
인쇄하기
취소
|
Viread, Truvada listed in green list
Several new drugs were recently listed in Korea’s green list which can be compared to the "Orange Book" in the USA, according to Yakup.com, a pharmaceutical information provider.
The data showed that new medicines registered into the list in January include Gilead Sciences’ Viread/Truvada, Boehringer Ingelheim’s Twynsta, Daiichi Sankyo’s Sevikar, AstraZeneca’s Brilinta, Merck’s Januvia, Dong...
The data showed that new medicines registered into the list in January include Gilead Sciences’ Viread/Truvada, Boehringer Ingelheim’s Twynsta, Daiichi Sankyo’s Sevikar, AstraZeneca’s Brilinta, Merck’s Januvia, Dong...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.